SCHEMBL21157384

SCHEMBL21157384

Cc1ccc(S(=O)(=O)OC(C)(C)CS(=O)(=O)OC(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CA2 P00918 4/20 0.36
CA1 P00915 3/20 0.36
GAA P10253 1/20 0.36
CNR2 P34972 2/20 0.36
GBA1 P04062 1/20 0.36
CYP24A1 Q07973 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
CA9 Q16790 3/20 0.35
CA12 O43570 2/20 0.35
VDR P11473 1/20 0.35
TSHR P16473 1/20 0.35
CA7 P43166 2/20 0.34
CA3 P07451 1/20 0.34
CA6 P23280 1/20 0.34
CA5A P35218 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20177414 0.80 ALDH1A1 (0.45) ALDH1A1MEN1KMT2ACA2CA1
SCHEMBL21157386 0.80 ALDH1A1 (0.49) ALDH1A1MEN1KMT2ACA2CA1
SCHEMBL15963902 0.79 ALDH1A1 (0.46) ALDH1A1MEN1KMT2ACA2CA1
SCHEMBL21930791 0.78 ALDH1A1 (0.41) ALDH1A1MEN1KMT2ACA2CA1
SCHEMBL8394723 0.77 ALDH1A1 (0.44) ALDH1A1MEN1KMT2ACA2CA1
SCHEMBL143705 0.76 GAA (0.50) ALDH1A1MEN1KMT2ACA2CA1
SCHEMBL14944048 0.76 ALDH1A1 (0.43) ALDH1A1MEN1KMT2ACA2CA1
SCHEMBL12461296 0.76 ALDH1A1 (0.47) ALDH1A1MEN1KMT2ACA2CA1
SCHEMBL18900307 0.76 ALDH1A1 (0.43) ALDH1A1MEN1KMT2ACA2CA1
SCHEMBL4127587 0.76 ALDH1A1 (0.43) ALDH1A1MEN1KMT2ACA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190209704-A1 NOVEL ANTIBODY-DRUG CONJUGATES AND RELATED COMPOUNDS, COMPOSITIONS AND METHODS OF USE SENSEI BIOTHERAPEUTICS, INC. 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190209704-A1 NOVEL ANTIBODY-DRUG CONJUGATES AND RELATED COMPOUNDS, COMPOSITIONS AND METHODS OF USE CYTH3, CD47, FCGRT ALDH1A1 2978/4885MEN1 1239/4885KMT2A 2145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.